US Patent Issued to McMaster University on Feb. 24 for "Method of diagnosing and treatment monitoring of crohn's disease and ulcerative colitis" (Canadian Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,560,617, issued on Feb. 24, was assigned to McMaster University (Ontario, Canada).

"Method of diagnosing and treatment monitoring of crohn's disease and ulcerative colitis" was invented by Philip Britz-McKibbin (Hamilton, Canada) and Nikhil Pai (Hamilton, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of diagnosing Crohn's disease and ulcerative colitis in subjects is provided based on the determination of metabolites in urine samples, such as serine, hypoxanthine, kynurenine, threonine, dimethylglycine, tryptophan, indoxylsulfate, phenylacetylglutamine, sialic acid, 5-hydroxy-6-indolyl-o-sulfate, 5-(triangle-carboxybutyl) homocysteine, a...